PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 60: Articles 29501-30000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraceptive prevalence and demographic trends in Paraguay.
  2. Contraceptive prevalence as a measure of family planning success. 2nd revision.
  3. Contraceptive questionnaire. (Letter to the editor)
  4. Contraceptive retail sales program: Jamaica.
  5. Contraceptive rings: self-administered treatment governed by bleeding.
  6. Contraceptive risk taking and abortion: results and implications of a San Francisco Bay area study.
  7. Contraceptive risk taking is termed intentional.
  8. Contraceptive sponge fights VD, too.
  9. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
  10. Contraceptive steroids and liver lesions.
  11. Contraceptive usage and other characteristics of 440 pregnant teenage patients at MCG in 1975.
  12. Contraceptive use and pregnancy planning in the Hutt Valley.
  13. Contraceptive use and subsequent fertility.
  14. Contraceptive use at a time of conception for pregnancies resulting in unwanted births.
  15. Contraceptive use effectiveness in Indonesia.
  16. Contraceptive use has changed dramatically since 1965.
  17. Contraceptive use.
  18. Contraceptive use.
  19. Contraceptive use. (Letter)
  20. Contraceptive use: prevalence among married women in Albany, New York, Health Region, 1974.
  21. The contraceptive vaginal suppository: results of a five years' clinical study.
  22. Contraceptive workload in general practice in the Trent Region.
  23. Contraceptives for men: what's new and practical?
  24. Contraceptives of yesterday, today, and tomorrow. [Contraccettivi di ieri, di oggi... e di domani.]
  25. A controlled intrauterine contraceptive device trial.
  26. Controlled study of the association between oral contraception and hepatocellular adenoma. (Abstract only)
  27. A controlled study of the effect of oral contraceptives on migraine patients. (Abstract only)
  28. A coordinated program at the NIH to evaluate the side-effects of methods of contraception: experiences and problems.
  29. Copper IUD as an alternative to hormonal contraception. [Das Kupfer-IUP als Alternative zur ''Pille.''.]
  30. Coptic church program includes family planning.
  31. Coronary thrombosis on oral contraception. [Thrombose coronaire apres contraception orale.]
  32. Correlates of field-worker performance in the Indonesian family planning program: a test of the homophily-heterophily hypothesis.
  33. Correlation of maternal contraceptive history with chromosomes, sex ratio and anthropometric measurements of the fetus and neonate.
  34. Cost-effectiveness of Pakistan's family planning programme.
  35. Costa Rica: contraceptives nationwide.
  36. Costa Rica: some information on population, family planning and maternal and child health.
  37. The costs of family planning programs: methodological issues with an application to Barbados.
  38. Counseling on family planning and human sexuality.
  39. The course of pregnancy and the state of the intrauterine fetus after the use of various contraceptives. [Tetchenye beremennosti i sostoianye onutrurobnovo ploda poslye primenenya rawlitchnikh sredstv contratseptsii.]
  40. Cribriform polypoid adenomatous (atypical) hyperplasia of the endocervical glands of the uterus under hormonal contraception.
  41. Criteria for choosing among oral contraceptives in Tunisia. [Criteres de choix des contraceptifs oraux en Tunisie.]
  42. Criteria for choosing oral contraceptives in Tunisia. [Criteres de choix des contraceptifs oraux en Tunisie.]
  43. Critical decisions of 1978 funding for family planning before Congress.
  44. Critical dosages for oral contraceptives.
  45. Current advances in family planning technology.
  46. Current status of family planning in Africa.
  47. Curriculum validation study for natural family planning instructor training.
  48. Cytologic, colposcopic and histologic modifications of the uterine cervix in oral contraception. [Modificazioni citologiche, colposcopiche ed istologiche del collo dell'utero durante trattamento con estro-progestinici.]
  49. d-norgestrel and megestrol acetate concentrations in maternal plasma and milk during administration of oral contraceptives to nursing women. (Abstract only)
  50. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives.
  51. Data and analyses for 1977 revision of DHEW five-year plan for family planning services.
  52. Data requirements for implementing the family planning progress in India.
  53. Deafness and oral contraception. [Surdite et contraception orale.]
  54. Decision-makers on family planning: the Bohol experience.
  55. Declines in the age and family size of family planning program acceptors: international trends.
  56. Deficiency of vitamin B6 in women taking contraceptive formulations.
  57. Defining family health needs, standards of care and priorities with particular reference to family planning.
  58. Delay in the diagnosis of cervical cancer in patients using hormonal contraceptives and IUDs. [Verschleppung der Diagnose "Zervixkarzinom" bei hormonaler Kontrazeption und IUD.]
  59. Demographic and social aspects of contraceptive sterilization.
  60. Demographic aspects of the family planning program in El Salvador.
  61. Demographic impact of family planning programme in Singur Area West Bengal.
  62. Demographic policy and family planning. [Politica demografica y planificacion familiar.]
  63. Denmark: control of contraceptives.
  64. Desexing birth control.
  65. Design of studies for the assessment of contraceptive drugs and devices.
  66. The detection of intra-uterine contraceptive devices by ultrasonic investigation.
  67. Determinants of family planning practice in rural Thailand.
  68. Determination of pregnancy duration following terminated hormonal contraception. [Zur Beurteilung der Schwangerschaftsdauer nach beendeter hormonal Kontrazeption.]
  69. Diagnostic investigation of a clientele seeking contraception in a general practice. [En diagnostisk undersogelse af et antikonceptionsklientel fra almen praksis.]
  70. Diaphragm use increasing, Planned Parenthood says.
  71. The diaphragm: the queen of contraception.
  72. Dietary folate intake and concentration of folate in serum and erythrocytes in women using oral contraceptives.
  73. Diffuse bilateral retinal periphlebitis in a young woman taking contraceptives. [Periphebite retinienne bilaterale diffuse chez une femme jeune sous contraceptif.]
  74. The diffusion of a population-related innovation: the Planned Parenthood affiliate.
  75. Digestive troubles caused by oral contraceptives. [Les accidents digestifs des contraceptifs oraux.]
  76. Directions for classification and indication of oral contraceptives. [Hinweise zur Klassifikation und Indikation oraler Kontrazeptiva.]
  77. Directory of providers of family planning and abortion services, 1977.
  78. Directory, family planning service sites, United States.
  79. Discussion (of pharmacology of steroid contraceptive drugs.)
  80. Discussion of points raised at the seminar on Sterilization and Oral Contraceptives.
  81. Discussion summary (of steroid contraception and thromboembolic disorders)
  82. The distribution of modern contraceptive means: a survey in a hospital department. [La diffusion des methodes modernes de contraception: Une etude dans une consultation hospitaliere.]
  83. Disturbances of lipid metabolism and increased vascular risk due to contraceptive steroids. [Perturbations du metabolisme lipidique et augmentation du risque vasculaire provoquees par les steroides contraceptifs.]
  84. Do non-steroidal methods of contraception affect lactation?
  85. Doctors, teenagers, and contraception. (Abstract only)
  86. Document on human reproduction, family planning and population dynamics November-December 1977.
  87. Domestic appropriations for family planning and research settled; foreign appropriations not yet final.
  88. Domiciliary family planning in Tunis: an essay evaluating different experiences. (Second Conference on Domiciliary Family Planning, Tunis, March 27-30, 1977) [Le planning familial a domicile en Tunisie: essai d'avaluation des differentes experiences.]
  89. Domiciliary family planning services: a reappraisal.
  90. The double-check method of family planning.
  91. Dream recall and oral contraceptives.
  92. Drug interactions with oral contraceptives: an overview.
  93. Drug interference with contraceptive effectiveness. [La pilule endormie.]
  94. Drug interference with laboratory tests: oral contraceptives.
  95. Dysplasias of uterine cervix. Epidemiological aspects: role of age at first coitus and use of oral contraceptives.
  96. The earliest influence of contraception on the incidence of conception. [Den tidligste pavirkning af konceptionstallet ved praevention.]
  97. The early birth control movement: an example of medical self-help.
  98. Early detection of cancer of the uterus in a family planning service. [Deteccion precoz del cancer de cuello uterino en un servicio de planificacion familiar.]
  99. Early experience in contraception with a new progestogen.
  100. An economic model of contraceptive choice: analysis of family planning acceptors in Bogota.
  101. Economic rationality and fertility decline: a research report based on in-depth interviews conducted in connection with survey research upon fertility and upon family planning outlook in Misamis Oriental and Southern Leyte Provinces, 1976.
  102. Ectopic pregnancies and the use of intrauterine device and low dose progestogen contraception.
  103. Ectopic pregnancies during use of low-dose progestogens for oral contraception.
  104. Education and birth control.
  105. Education and contraceptive knowledge in rural areas of four Latin American nations.
  106. The effect of an oral contraceptive on plasma concentrations of dehydroisoandrosterone sulfate and ACTH. (Abstract only)
  107. Effect of an oral contraceptive on plasma dehydroepiandrosterone concentrations.
  108. The effect of an oral contraceptive on serum lipoproteins and skinfold thickness in young women.
  109. Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive.
  110. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: 3. Medroxyprogesterone acetate.
  111. Effect of contraceptive steroids on human lactation.
  112. The effect of contraceptive steroids on hypothalamic-pituitary function.
  113. Effect of contraceptive steroids on vascular connective tissue dynamics in the rat. (Abstract only)
  114. Effect of ethynodiol diacetate and a combination-type oral contraceptive compound on carbohydrate metabolism. 2. One-year glucose tolerance study.
  115. The effect of induced abortion and contraceptive practice on pre- and post-war Japan.
  116. Effect of intrauterine contraception on nonspecific reactivity of the female body. [Vlianye vnutrimatobchnoy contratseptsii na nespetshiphitcheskuyu reactivnost organizma shenshinyi.]
  117. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. 1. Blood and urinary lactate, uric acid, and phosphorus.
  118. Effect of low zinc intake and oral contraceptive agents on nitrogen utilization and clinical findings in young women.
  119. Effect of norgestrel-releasing intrauterine contraceptive devices on plasma steroid levels in Erythrocebus patas. (Abstract only)
  120. Effect of oral alanine loads on the serum triglycerides or oral contraceptive users and normal subjects.
  121. The effect of oral contraceptive agents on plasma Vitamin A in the human and the rat.
  122. The effect of oral contraceptive steroids on branches of the uterine artery.
  123. Effect of oral contraceptive therapy on gingival inflammation in humans. (Abstract only)
  124. The effect of oral contraceptives and of bromocriptin upon pituitary stimulation by LH-RH and TRH. (Abstract only)
  125. Effect of oral contraceptives on ascorbic acid status of young women consuming a constant diet.
  126. Effect of oral contraceptives on blood folate levels in pregnancy.
  127. The effect of oral contraceptives on colour vision in diabetic women.
  128. Effect of oral contraceptives on Factor 8 clotting activity and Factor 8 related antigen in known haemophilia carriers. (Abstract only)
  129. Effect of oral contraceptives on levels of thyroid hormone, blood coagulation and ceruloplasmin. [Beeinfluss ung von Schilddrusenhormonspiegel, Blutgerinnung und Zoruloplasmin durch Ovulationshemmer.]
  130. Effect of oral contraceptives on micronutrients and changes in trace elements due to pregnancy.
  131. Effect of oral contraceptives on plasma testosterone concentration. (Letter)
  132. Effect of oral contraceptives on resting blood flow in the leg.
  133. Effect of oral contraceptives on sebum excretion rate.
  134. Effect of oral contraceptives on the absorption of stable isotopes of iron, copper and zinc. (Abstract only)
  135. Effect of oral contraceptives on the production and composition of human milk.
  136. The effect of recent FDA legislation on contraceptive development and safety.
  137. Effect of steroid contraceptive drug treatment on the catecholamine metabolism in the guinea pig central nervous system.
  138. Effect of steroidal contraception on lipid factors and liver function tests.
  139. Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives.
  140. Effectiveness of a programmed instruction module on oral contraceptives.
  141. Effectiveness of contraception in Belgium: results of the second national fertility survey, 1971 (NEGO II)
  142. Effectiveness of the sympto-thermal method of natural family planning.
  143. Effectiveness of the sympto-thermal method of natural family planning: an international study.
  144. Effectiveness of the use of contraception in the voluntary family planning program of the Instituto Mexicano del Seguro Social. [Efectividad en el uso de anticonception en el programa de planificacion familiar voluntaria, del Istituto Mexicano del Seguro Social.]
  145. The effects of a "low-estrogen" oral contraceptive on carbohydrate metabolism during six months of treatment: a preliminary report of blood glucose and plasma insulin values.
  146. The effects of an oral contraceptive on plasma growth hormone and glucose tolerance in 2 strains of rats.
  147. Effects of an oral contraceptive on the EEG and heart rate. (Abstract only)
  148. The effects of classical and low-dose oral contraceptives on cervical mucus framework.
  149. Effects of contraceptive steroids and pregnancy on bile composition and kinetics in the baboon.
  150. Effects of contraceptive steroids on carbohydrate and lipid metabolism. [Incidences metaboliques de la contraception hormonale.]
  151. Effects of hormonal contraception in the adolescents. [Effectos de la anticonception hormonal oral en la adolescente.]
  152. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation Factors 7 and 10.
  153. Effects of long-acting steroid contraceptives on ovarian and uterine histology of rats.
  154. Effects of long-term treatment with contraceptive steroids on plasma and brain tryptophan, brain 5-hydroxytryptamine, and locomotor activity in female mice.
  155. Effects of menstrual cycle and of oral contraceptives on psychological performances and mood in women. (Abstract only)
  156. Effects of oral and intrauterine administration of contraceptives on the uterus.
  157. Effects of oral contraceptive agents on the lower esophageal sphincter (LES). (Abstract only)
  158. Effects of oral contraceptive steroids on pituitary function. (Abstract only)
  159. The effects of oral contraceptives on the health of Nigerian women.
  160. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months.
  161. Effects on the endometrium of a new oral contraceptive: Physiostat. [Effets sur l'endometre d'un nouveau contraceptif oral: le Physiostat.]
  162. Egypt boosts family planning.
  163. Electrical activity of rat brain and heart after an oral contraceptive. (Abstract only)
  164. Electrocardiographic abnormalities in women taking oral contraceptives. (Letter)
  165. Elevated caffeine and ethynylestradiol blood levels in hypertensive oral contraceptive users.
  166. Eleven years of family planning in Colombia: use of methods and programs 1965-1975.
  167. Empirical demographic generalizations in response to family planning programs.
  168. Encouraging contraception by emphasizing VD protection.
  169. Endocrine aspects of contraception and abortion.
  170. Endometrial carcinoma and oral contraceptive agents.
  171. Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users.
  172. Endometrial histology with oral contraceptives.
  173. Epidemiologic studies on the effect of oral contraceptives on subsequent pregnancies.
  174. Epidemiological studies on the effect of oral contraceptives on subsequent pregnancies.
  175. An epidemiological study of intrauterine contraceptive devices - a preliminary report.
  176. Epidemiology of the need for family planning as derived from maternity care monitoring. (Selected charts)
  177. Epileptiform convulsions during insertion of intrauterine contraceptive device. (Letter)
  178. Erosive colitis in patients taking oral contraceptives. [Colite erosive chez des malades prenant des contraceptifs oraux.]
  179. Eruptions due to oral contraceptives.

     

  180. Erythema nodosum and oral contraceptives. (Letter)
  181. Erythema nodosum associated with pregnancy and oral contraceptives.
  182. Estimating family planning program effects on U.S. fertility rates.
  183. Estrogen-free contraceptive studied.
  184. The ethics of supervising family planning in developing nations.
  185. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive.
  186. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives.
  187. The Euiryong experiment: a Korean innovation in household contraceptive distribution.
  188. Evaluating the effectiveness of the utilization of traditional birth attendants (Hilots) as family planning motivators in the Philippines.
  189. Evaluation and reporting schemes of family planning activities in a combined project.
  190. An evaluation of 10 years of family planning in Chile. [Evaluacion de 10 anos de planificacion de la familia en Chile.]
  191. The evaluation of a family planning program in terms of continuation. [L'evaluation d'un programme de planification familiale en termes de continuation.]
  192. Evaluation of Hypercoagulability in users of oral contraceptives.
  193. The evaluation of sex chromatin number of newborns of mothers using oral contraceptives prior to contraception.
  194. Evaluation of the Mexican Institute of Social Security's voluntary family planning program. I. General findings: demographic and socioeconomic characteristics. [Evaluacion del programa de planificacion familiar voluntaria del Instituto Mexicano del Seguro Social. I. Generalidades: caracteristicas socioeconomicas y demograficas.]
  195. Evaluation of the program of voluntary family planning of the Instituto Mexicano del Seguro Social. [Evaluacion del programa de planificacion familiar voluntaria del Instituto Mexicano del Seguro Social.]
  196. Evaluation report on family planning promotion through home economics (AHEA - AID/csd-3623)
  197. Evaluation report to UNFPA on clearinghouses and documentation centers in the field of population and family planning in Asia.
  198. Evidence of higher ethynylestradiol blood levels in human hypertensive oral contraceptive users.
  199. Evolution of a supervision group of female family planning consultants before and after the Veil law on abortion. [Evolution d'un groupe de supervision d'hotesses du planning familial avant et apres la loi Veil.]
  200. The evolution of family planning in an African city: Ibadan, Nigeria.
  201. Experience with medroxyprogesterone acetate (Depo-Provera) as an injectable contraceptive.
  202. Experience with the combined multiload Cu 250 contraceptive.
  203. An experimental design for assessing the effectiveness of household contraceptive distribution.
  204. Experimental efforts in family planning programs.
  205. Experimentation in family planning delivery systems: an overview.
  206. Experiments in family planning: lessons from the developing world.
  207. Expert group meeting on methods of measuring the impact of family planning programmes on fertility.
  208. Extensive actinomycosis associated with an intrauterine contraceptive device.
  209. Extent of demand for exclusive private family planning clinics among urban middle classes.
  210. Extrauterine pregnancy and contraception. (Letter)
  211. (Extrauterine pregnancy and contraception.) (Letter))
  212. (Extrauterine pregnancy and contraception.) (Letter))
  213. Eye examinations in long term use of hormonal contraceptives. [Augenuntersuchungen bei Langzeitmedikation hormonaler Kontrazeptiva.]
  214. Factors affecting contraceptive practices of high school and college-age students.
  215. Factors affecting the use of contraception in the nonmarital context.
  216. Factors associated with high and low family planning acceptance in Karnataka State.
  217. Factors influencing contraceptive behavior of single college students.
  218. Factors influencing the implementation of voluntary sterilization as a family planning contraceptive in the South Asia region.
  219. Failure of oral contraception, presumably on account of interaction with phenemal. [P-pillesvigt: antagelig pa grund af interaktion med fenemal.]
  220. Fall in NYC abortions in '75 is credited to birth control.
  221. Family health and birth control.
  222. Family planning - the untraditional way.
  223. Family planning acceptance, benefits and involvement--an experiment in an urban slum.
  224. Family planning and birth control counselling. (Letter)
  225. Family planning and election manifestos.
  226. Family planning and fertility decline: a global overview.
  227. Family planning and health: the vital connection.
  228. Family planning and hormonal contraceptives. [Familienplanung und hormonale Kontrazeptiva.]
  229. Family planning and marital counselling in GDR.
  230. Family planning and population education in home economics: a sourcebook for teachers [resource catalog and teaching units]
  231. Family planning and population education in home economics: resource catalog.
  232. Family planning and population in the People's Republic of China.
  233. Family planning and population policy in China. [Familieplanlegging og befolkningspolitikk i Kina.]
  234. Family planning and sex education: the Chinese approach.
  235. Family planning and sexuality.
  236. Family planning and sterilization in Panama. [Planificacion familiar y esterilizacion en Panama.]
  237. Family planning and the primary care physician.
  238. Family Planning and Women's Development Conference, 9-12 August 1977. Monastir (Tunisia)
  239. Family planning attitudes and practices in rural Eastern Nigeria.
  240. Family planning based on genetic counseling. [Familienplanung durch genetische Beratung.]
  241. Family planning between the idea and the implementation.
  242. Family planning cited as key health care component.
  243. The family planning clinic record.
  244. Family planning communication policy in India -- implications for research.
  245. Family planning communication reach study.
  246. Family planning concepts: myths and realities.
  247. Family planning decision-making: a comparison and analysis of parents' considerations.
  248. Family Planning education and services...an evaluation of pilot projects.
  249. Family planning education found worthy of 'universal' public support.
  250. The family planning factor.
  251. Family planning for psychiatric patients.
  252. Family planning found effective in reducing birthrates; works best combined with socioeconomic development.
  253. Family planning funds increased tenfold since FY 1971 while staff remained constant.
  254. Family planning halves abortions.
  255. Family planning helps in Sri Lanka.
  256. Family planning in a sample of Edinburgh women.
  257. Family planning in America. [Planificacion familiar en America.]
  258. Family planning in an industrial set-up: acceptability and follow-up problems.
  259. Family planning in Chile, 1952-1977. [La planificacion de familia en Chile, 1952-1977.]
  260. Family planning in Chile, 1952-1977. [La planificacion de familia en Chile, 1952-1977.]
  261. Family planning in China.
  262. Family planning in China.
  263. Family planning in Haryana: analysis of a state program in India.
  264. Family planning in Iloilo: demographic and psychological perspectives.
  265. Family planning in India (a descriptive analysis)
  266. Family planning in industry in the Asian Region. Pt. 1. The manual.
  267. Family planning in industry in the Asian region. Pt. 2. Some action studies.
  268. Family planning in Mauritius.
  269. Family planning in Mauritius: a national survey.
  270. Family planning in socialist countries: the legal and actual status.
  271. Family planning in South Africa. (Letter)
  272. Family planning in South Africa. [Gesinsbeplanning in Suid-Afrika.]
  273. Family planning in the Goroka area of the Eastern Highlands.
  274. Family planning in the Greater Cape Town area: a background study.
  275. Family planning in the People's Republic of China.
  276. Family planning in the People's Republic of China. [Le planning familial en Chine Populaire.]
  277. Family planning in Tunisia.
  278. Family planning in Tunisia. [La planification familiale en Tunisie.]
  279. Family planning in Tunisia: an attempt to evaluate different household distribution experiments.
  280. Family planning knowledge and practice in an area in Greater Bombay.
  281. Family planning knowledge, attitude and practice in Hong Kong: a survey report based on a colony-wide random sample of selected households, 1977.
  282. Family planning legislation in the Francophone countries of Africa.
  283. Family planning medical kits, 1976-1977.
  284. Family planning method change and dropouts in the Philippines.
  285. Family planning more than a question of marketing. [Familieplanering mer an en graga om marknadsforing.]
  286. The family planning nurse practitioner: suggested guidelines for role expansion and utilization.
  287. Family planning or birth control: the Ghanaian contradiction.
  288. Family planning performance statistics.
  289. Family planning procedure manual for nurse-midwives 1977. 3rd. ed.
  290. Family planning program activity and patient enrollment rates in the United States, 1969 and 1971.
  291. Family planning program as being carried by CEOSS.
  292. Family planning program effects on natality: a comparison of matched acceptor and nonacceptor birth rates in Malaysia.
  293. A family planning program for the Honduran campesino (a supplemental report)
  294. Family planning program in Korea.
  295. The family planning program in the socioeconomic context: demand, infrastructure, and substitution.
  296. Family planning program: 26% of reproductive-age Filipinos.
  297. Family planning program: big strides in 10 years.
  298. Family planning programs in Britain, German Federal Republic, Denmark and Sweden, with the implications for Canada.
  299. Family planning progress in Maharashtra.
  300. Family planning service delivery: options and trends.
  301. Family planning service statistics. Annual report 1976.
  302. Family planning services in the United States of America. [Los servicios de planificacion de la familia en Estados Unidos de America.]
  303. Family planning statistics, India] [Tables.
  304. Family planning statistics--information system.
  305. Family planning under the magnifying glass (with special consideration of the Indian situation) [Gesinsbeplanning onder die loepe (met spesiale verwysning na die Indiese verkiesing.]
  306. Family planning with third-world males.
  307. Family planning, an exciting world: my experience of a social service year. [Planificacion familiar, un mundo apasionante. La experiencia de mi and social.]
  308. Family planning.
  309. Family planning.
  310. Family planning.
  311. Family Planning. (Editorial)
  312. Family planning: a crucial programme.
  313. Family planning: history, programs and practice.
  314. Family planning: the Muslim viewpoint.
  315. Family planning: where now??
  316. Family size and attitude of Syrian women toward contraception. [Dimension de la famille et attitude des femmes syriennes a l'egard de la contraception.]
  317. Family spacing and limitation: applying family planning in rural communities.
  318. Family type and attitude of newly married males towards appropriateness of their age at marriage, desired family size and family planning.
  319. Fatal outcome of a hepatic adenoma following short term oral contraceptive use.
  320. Favoured methods of family planning in different socio-economic groups.
  321. Fear that abortion will be used as an alternative to contraception held unjustified.
  322. Fears of gynecologic cancer being caused by oral contraceptives 'almost baseless.'.
  323. Feminism, philanthropy and science in the development of the oral contraceptive pill.
  324. Fertility and family planning amongst hutment dwellers of Patna.
  325. Fertility and family planning in a remote hill area in Himachal Pradesh.
  326. Fertility and family planning in Hungary.
  327. Fertility and family planning in Nabatieh: a field study conducted in the Nabatieh District in August of 1976.
  328. Fertility awareness: four methods of natural family planning.
  329. Fertility control in man: the history of contraception from antiquity to modern times (author's transl) [Fertilitetskontroll hos maenniskan: preventivmedlens historia fraan forntid til nutid.]
  330. Fertility decline and family planning in Colombia, 1964-1975. [Descenso de la fecundidad y planificacion familiar en Colombia 1964-1975.]
  331. Fetal loss, twinning and birth weight after oral-contraceptive use.
  332. FFPA (Federation of Family Planning Association) study reveals a high rate of induced abortions.
  333. Fibrin formation and dissolution in women receiving oral contraceptive drugs.
  334. A field survey of oral contraceptives with patient pairs out of gynecological practices (Pilot - III)
  335. Fighting opium with family planning.

     

  336. Filling the gaps in family planning.
  337. Final Evaluation Survey of Industrial Family Planning Programmes in Korea. (author's transl)
  338. Final report: comparative oral contraceptive studies.
  339. Fine points of the sympto-thermal method of natural family planning.
  340. Fine points of the sympto-thermic method of natural family planning. No. 2.
  341. First national course in communication in social development and population programs. Areas: family planning, sex education, Caracas, Venezuela, May 2 to 31.
  342. First World Congress on Natural Family Planning, organized by FIDAF, Federation International de Accion Familiar, Cali, Colombia, June 22-26, 1977. [1er. Congreso Mundial de Planificacion Natural de la Familia, organizado por la FIDAF, Federacion Internacional de Accion Familiar, Cali, Colombia, Junio 22-26, 1977.]
  343. Flavonoid extract offsets contraceptives' side effects.
  344. Focus on family planning measures.
  345. Forearm blood flow, venous distensibility and clotting factors during pregnancy and under oral contraceptives. (Abstract only)
  346. FP/MIS: a management information system for a community family planning clinic.
  347. Free-standing subsidized family planning clinics: the manpower cost of patient services.
  348. The future of reversible masculine contraception. [L'avenir de la contraception masculine reversible.]
  349. Gas exchange and acid-base status during the normal human menstrual cycle and in subjects taking oral contraceptives. (Abstract only)
  350. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives.
  351. The great tabu; a half century of population and family planning communication.
  352. A guideline for the integrated family planning program.
  353. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 mcg or 30 mcg of oestrogen.
  354. HCG-neutralizing vaccine a new contraceptive?
  355. Headaches during oral contraception. A selective study concerning 159 observations. [Les cephalees au cours de la contraception oral. Etude selective a l'aide de 159 observations.]
  356. Headaches, migraine and oral contraception. [Cephalees, migraines et contraception orale.]
  357. The health belief model and contraceptive behavior: limits to the application of a conceptual framework.
  358. The Health Belief Model as a conceptual framework for explaining contraceptive compliance.
  359. Health: the family planning factor.
  360. Hemodynamic effects of oral contraceptives during exercise.
  361. Hemophilus parainfluenzae peritonitis associated with an intrauterine contraceptive device.
  362. Hepatic adenoma and oral contraceptive therapy.
  363. Hepatic adenomas and focal nodular hyperplasia of the liver in young women on oral contraceptives: case reports.
  364. Hepatic changes caused by contraceptive steroids. [Alteraciones hepaticas producidas por esteroides anticonceptivos.]
  365. Hepatic tumors and oral contraceptives.
  366. Hepatic tumors associated with oral contraceptives) (Abstract only. [Lebertumoren unter Ovulationshemmern.]
  367. Hepatic tumors: possible relationship to use of oral contraceptives.
  368. Hepatic vein thrombosis in women taking oral contraceptives: a case report.
  369. Hepatoblastoma in an infant after contraceptive intake during pregnancy. (Letter)
  370. Hepatocellular carcinoma in a woman on long-term oral contraceptives.
  371. Hepatocellular carcinoma: a possible complication of oral contraceptive steroids.
  372. Hepatotoxicity and the oral contraceptives. (Letter)
  373. Hereditary coproporphyria presenting with photosensitivity induced by the contraceptive pill.
  374. High and very high dosages of the oral contraceptive lynestrenol: a three-month feeding study in female rats.
  375. High Court rules minors under 16 can buy contraceptives; overturns restrictions on contraceptive sales, advertising.
  376. His turn? Methods of contraception for men.
  377. Historical perspective on intravaginal contraceptive sponges.
  378. The history and politics of contraception.
  379. History of contraception and its development in Britain.
  380. History of the birth control movement.
  381. History of the first oral contraceptive.
  382. Oral contraceptives, anti-thrombin 3 and fibrinolytic activity in Africans.
  383. Oral contraceptives, hepatic adenomas and liver scans.
  384. Oral contraceptives, smoking, and venous thromboembolism. (Letter)
  385. Oral contraceptives, thromboembolic disease, and hypertension: a review.
  386. Oral contraceptives.
  387. Oral contraceptives: a demographic survey of military dependents.
  388. The history of the Korean VSC [voluntary surgical contraception] effort.
  389. Hormonal contraception and future pregnancies.
  390. Hormonal contraception and nutrition.
  391. Hormonal contraception and pregnancy. [Contraception hormonale et grossesse.]
  392. Hormonal contraception and vaginal mycoses. [Contrception hormonale et mycoses vaginales.]
  393. Hormonal contraception. [Gormonalnaya kontratseptsiya.]
  394. Hormonal contraception. [La contraception hormonale.]
  395. Hormonal contraception: current perspectives Part 1. An analysis of available agents.
  396. Hormonal contraception: perspectives part two. Special techniques.
  397. Hormonal contraceptives and periodontium. [Ovulationshemmer und Parodontium.]
  398. Hormonal evaluation of the intrauterine progesterone contraceptive system.
  399. Hormones, hormone antagonists, and contraceptives.
  400. House OKs overseas family planning authorization after sterilization debate.
  401. House subcommittee hears testimony on extension of family planning legislation.
  402. Household contraceptive distribution in Menoufia Governorate, Egypt.
  403. Household distribution of contraceptives in Bangladesh - rural experience.
  404. Household distribution of contraceptives in Bangladesh - the urban experience.
  405. Household distribution of contraceptives in Bangladesh -- the rural experience.
  406. Household distribution of contraceptives survey.
  407. Household distribution of oral contraceptives survey.
  408. How family planning affects health.
  409. How some doctors handle consultations on contraception.
  410. How to differentiate monophasic contraceptives. [Jak rozlisovat jednofazova steroidni kontraceptive?]
  411. Human metabolism and steroid contraceptives.
  412. Human metabolism and steroid contraceptives. Pt. 2.
  413. Human reproduction, family planning and population dynamics.
  414. Humanistic family planning--new approach to integrated project: how to promote activities in model pilot areas.
  415. Hysteroscopic removal of intrauterine contraceptive devices with missing threads.
  416. Illiteracy plus family planning by card game.
  417. Immediate post-placental insertion of intrauterine contraceptive devices.
  418. Immunologic control of fertility: search for a contraceptive vaccine.
  419. The impact and the secondary effects of contraception. [Impacto y efectos secundarios de la anticonception.]
  420. Impact of family planning programs on fertility: the U.S. experience.
  421. The impact of family planning programs on unplanned pregnancies.
  422. The impact of personal characteristics on postabortion contraceptive acceptance.
  423. The impact of plasma protein binding of contraceptive steroids upon their concentration in human milk. (Abstract only)
  424. Impact of the abortion experience on contraceptive acceptance.
  425. Impact of US family planning programs.
  426. Implementation of cost accounting principles in family planning projects.
  427. Implications of changes in hexosaminidase (HEX) activity during pregnancy and following oral contraceptive steroids (OCs). (Abstract only)
  428. The importance of risk factors in cerebrovascular processes while taking oral contraceptives. [Uber die Bedeutung des Risikofaktors bei zerebrovaskulaeren Prozessen unter Ovulationshemmer-Einnahme.]
  429. Impressions of the 1977 National Conference in Maternal and Child Welfare and Family Planning.
  430. The incidence of cervical cancer and duration of oral contraceptive use.
  431. Incidence of hypertension during use of contraceptives (Abstract only) [Hochdrunckhaeufigkeit unter Ovulationshemmereinnahme.]
  432. Incidence of hypertension in the course of taking contraceptives. [Hochdruck-Haeufigkeit unter Ovulationshemmereinnahme.]
  433. Incidence of hypertension in the Walnut Creek contraceptive drug study cohort.
  434. Increased incidence of postoperative localized osteitis in mandibular third molar surgery associated with patients using oral contraceptives.
  435. Increased risk of breakthrough bleeding when one oral-contraceptive tablet is missed.
  436. Increased risk of hepatocellular adenoma in women with long-term use of oral contraception.
  437. Increased risk of hepatocellular adenoma in women with long-term use of oral contraception.
  438. India: New family planning program direction outlined.
  439. Indonesia's family planning story: success and challenge.
  440. An inert intracervical contraceptive device: a preliminary clinical trial.
  441. Infertility and disturbances of the menstrual cycle after oral contraception. (Abstract only)
  442. Influence of contraceptive steroids on the turnover of plasma free arachidonic and oleic acids.
  443. Influence of menstrual hygiene and method of contraception on PH and bacterial infection of vagina. [Einfluss von Menstruationshygiene - Tampons bzw. binden - und art der Kontrazeption auf PH und Bakterienbesiedlung der Schiede.]
  444. Influence of oral contraceptive agents on the concentration of amino acids in leukocytes of supposedly healthy women. [Influence des contraceptifs oraux sur la concentration des acides amines granulocytaires chez les femmes supposees saines.]
  445. Influence of oral contraceptives on breast diseases.
  446. Influence of oral contraceptives on the acute effect of amphetamine on the hepatic endoplasmic reticulum of the rat.
  447. The influence of sucrose and starch diets and oral contraceptives on the serum lipid responses of young women. (Abstract only)
  448. The influence of sucrose and starch diets and oral contraceptives on the serum lipid responses of young women. Doctoral dissertation, University of Maryland, 1976.
  449. The influence of the hippocampus on luteinizing action of adenohypophysis and contraceptive activity of megestranol. [Vliyanie gippokampa na lyutiziruyuschuyu aktivnost adenogipofiza i kontratseptivnuyu aktivnost megestranola.]
  450. The influence of thiamin deficiency on the metabolism of the oral contraceptive mestranol (3-methoxy-17-ethynyl-1,3,5(10)-estratrien-17 beta-ol) by female rat liver enzymes.
  451. Information needs and uses in population/family planning: a collaborative research project.
  452. Information package on current status of population and family planning policies and programs in sub-Saharan Africa.
  453. Injectable contraception (medroxyprogesterone acetate) in rural Bangladesh.
  454. Injectable contraceptive preparations.
  455. Injectable contraceptives endorsed by PGH specialist.
  456. Injectable contraceptives in six villages of Matlab Thana, Bangladesh: initial experience.
  457. Injectable contraceptives.
  458. Injectable contraceptives: the alleged risk that was not proven.
  459. Injectable depot contraceptive on d-norgestrel basis: . 1. pharmacokinetic studies in dog and baboons.
  460. Injectable depot contraceptives on d-norgestrel basis. 2. Clinical pharmacokinetic studies with d-norgestrel undecyclate in women.
  461. Instructional manual for conducting field studies in the use and non-use of MCH/family planning services.
  462. Integrated approach at grassroots level towards family planning and health programme with particular emphasis on nutrition and parasite control. (A report on the Joint JOICFP/IGCC Workshop, Genting Highlands and Kuala Lumpur, Malaysia, March 23-25, 1977)
  463. An integrated program of family planning, parasite control, and nutrition components in Korea.
  464. Integrating family planning with development programmes.
  465. Integrating family planning with nutrition and parasite control.
  466. Integration of family planning and maternal and child health services: problems of and the safeguards required.
  467. Integration of health, nutrition, and family planning: the Companiganj project in Bangladesh.
  468. Integration of MCH, family planning and nutrition programs from a managerial perspective.
  469. Intelligence quotient in offspring of oral and non-oral contraceptive. 2nd part.
  470. Interactions of contraceptive steroids with human placental cytochrome P-450 (P-450hpm). (Abstract only)
  471. Interest increasing for male contraceptive pill.
  472. Intermittent claudication in premenopausal women: A correlation with the long-term use of oral contraceptives?
  473. Intermittent claudication in premenopausal women: a correlation with the long-term use of oral contraceptives?
  474. International training of family planning and parasite control project personnel in Taiwan, Republic of China--a proposal.
  475. Intra-uterine contraceptive devices.
  476. An intracervical contraceptive device.
  477. Intrafamily decision making in family planning.
  478. Intrauterine contraception as a valid alternative. [La contraccezione intrauterina come valida alternativa alla pillola. Contemporary.]
  479. Intrauterine contraception in diabetic women.
  480. Intrauterine contraception.
  481. Intrauterine Contraception.
  482. Intrauterine contraception. ed. 4.
  483. Intrauterine contraception. [Vnutrimatochnaya kontratseptsiya.]
  484. Intrauterine contraceptive devices (IUDs) (author's transl) [Intrauterine Pessare (IUP)]
  485. Intrauterine contraceptive devices: professional and patient labeling.
  486. Intrauterine copper contraceptive safe and effective for three years, study shows.
  487. Intrauterine deposition of calcium on copper-bearing intrauterine contraceptive devices.
  488. Intrauterine release of estriol for contraception. Pt. 1. In vivo results.
  489. Intrauterine release of estriol for contraception. Pt. 2. Device fabrication and in vitro release rates.
  490. Intravaginal contraception: results of a prospective long-range study of foam capsules. [Intravaginale Kontrazeption: Ergebnisse einer prospektiven Langzeitstudie ueber das Schaumovulum.]
  491. Introduction (to the Contraceptive Revolution)
  492. Introduction and summary (to experiments in family planning)
  493. Investigation of a new low-dose oral contraceptive: 30 mcg ethinyl estradiol and 150 mcg levonorgestrel (d-norgestrel)
  494. Investigations on the contraceptive action of the Grafenberg ring. Historical review. [Untersuchungen uber die kontrazeptive Wirkung des Grafenberg-Ringes. Eine historische Reminiszenz.]
  495. Involvement of local dais in MCH and family planning programs. "Training of indigenous dais."
  496. Involvement of traditional midwives (dais) in MCH and family planning under India Population Project, Uttar Pradesh.
  497. IPPF survey of unmet needs in family planning 1971-76.
  498. IPPF survey of unmet needs in family planning, 1971-76: this report covers the main findings of the IPPF Unmet Needs Survey presented by the Secretary General to the Members Assembly, Edinburgh, 1977.
  499. Is contraception really accessible to adolescents? [L'acces des jeunes a la contraception.]
  500. Is oral contraceptive therapy advisable in woman with family history of breast cancer?

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.